找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: China Food and Drug Law; Policy, Practice, an John C. Balzano Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive li

[复制链接]
查看: 17567|回复: 44
发表于 2025-3-21 17:56:59 | 显示全部楼层 |阅读模式
书目名称China Food and Drug Law
副标题Policy, Practice, an
编辑John C. Balzano
视频videohttp://file.papertrans.cn/243/242092/242092.mp4
概述Provides full coverage of Chinese Food and Drug Regulation.Combines theory, policy, and practice into one discussion.Usable by experts but also user-friendly for those with no experience
丛书名称Law for Professionals
图书封面Titlebook: China Food and Drug Law; Policy, Practice, an John C. Balzano Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive li
描述.This book is an analysis of policy and law governing the development, approval, manufacture, distribution, marketing and post-market surveillance of human drugs, medical devices, foods and cosmetics in Mainland China (“China FDD Regulation”)...It analyzes the policy and general principles behind China FDD Regulation, including the history and jurisdiction of the central and local agencies that administer the laws and regulations, the administrative law structure in which these agencies operate, and other aspects of FDD Regulation interpretation and enforcement.  Although it describes practice in China, this book is written in the comparative perspective (i.e., sensitive to assumptions made by those who are steeped in FDD Regulation in the U.S., Japan, and the EU)...It includes one chapter on each regulatory space (drugs, medical devices, cosmetics, and food) organized by the lifecycle of products. It also covers subcategories of products, such as vaccines, radiopharmaceuticals, and in vitro diagnostic medical devices. The book includes specialty chapters on areas that are common to multiple types of regulated products, such as biosecurity and advertising...It is the first English
出版日期Book 2024
关键词Chinese Food Law; Chinese Drug Law; Human drugs; Cosmetics; Medical devices; China FDD Regulation; Biosecu
版次1
doihttps://doi.org/10.1007/978-3-031-61901-4
isbn_softcover978-3-031-61903-8
isbn_ebook978-3-031-61901-4Series ISSN 2662-141X Series E-ISSN 2662-1428
issn_series 2662-141X
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称China Food and Drug Law影响因子(影响力)




书目名称China Food and Drug Law影响因子(影响力)学科排名




书目名称China Food and Drug Law网络公开度




书目名称China Food and Drug Law网络公开度学科排名




书目名称China Food and Drug Law被引频次




书目名称China Food and Drug Law被引频次学科排名




书目名称China Food and Drug Law年度引用




书目名称China Food and Drug Law年度引用学科排名




书目名称China Food and Drug Law读者反馈




书目名称China Food and Drug Law读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:15:34 | 显示全部楼层
Designing Effective Content Marketing Postsin China. These laws not only control promotional content, but also influence informational and scientific exchanges, as well as the design and review of labels and package inserts in all the product spaces discussed in the preceding chapters. This Chapter is a discussion of this area and its unique features.
发表于 2025-3-22 01:57:23 | 显示全部楼层
John C. BalzanoProvides full coverage of Chinese Food and Drug Regulation.Combines theory, policy, and practice into one discussion.Usable by experts but also user-friendly for those with no experience
发表于 2025-3-22 05:26:45 | 显示全部楼层
发表于 2025-3-22 12:48:38 | 显示全部楼层
发表于 2025-3-22 16:06:09 | 显示全部楼层
发表于 2025-3-22 20:32:02 | 显示全部楼层
Adverse Events with Biomedicinessdiction, and key parts of their roles in creating food, drug, device, and cosmetic regulatory policy and regulations and in implementing and enforcing those regulations. This chapter devotes particular time to the history, internal structure, and affiliated centers for drug and device evaluation of
发表于 2025-3-22 22:10:33 | 显示全部楼层
发表于 2025-3-23 04:58:10 | 显示全部楼层
https://doi.org/10.1007/978-88-470-5313-7ossible to discern common principles and trends that pervade them. This chapter provides an introduction to these common elements to assist with understanding the specific analyses for each area that follow. By looking at the commonalities, it is possible to begin to understand China’s overall FDD r
发表于 2025-3-23 07:32:13 | 显示全部楼层
Adverse Events with Biomedicinesn over the life cycle of a drug, from development to the post-marketing environment. From 2015 to 2023, China has taken steps to transform itself from a generic drug market to an innovative one, where the latest medicines are available. To facilitate this change, it has tried to harmonize its drug r
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-18 03:48
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表